Stepan (NYSE:SCL) Issues Quarterly Earnings Results, Beats Expectations By $0.21 EPS

Stepan (NYSE:SCL) announced its earnings results on Wednesday. The basic materials company reported $0.94 earnings per share for the quarter, beating the consensus estimate of $0.73 by $0.21, FiscalAI reports. The business had revenue of $692.15 million for the quarter, compared to the consensus estimate of $634.30 million. During the same period in the previous year, the firm earned $0.48 EPS. The firm’s revenue was up 17.3% on a year-over-year basis.

Here are the key takeaways from Stepan’s conference call:

• Third-quarter adjusted EBITDA rose 18% to $66.3 million, while adjusted EPS nearly doubled to $0.94, supported by 7% organic volume growth, margin recovery, and productivity savings across all three segments.
• Surfactants led performance with adjusted EBITDA up 27%, while Specialty Products benefited from 20% volume growth in MCT products and North American Polymers delivered double-digit volume growth.
• Project Catalyst savings are running ahead of plan, with a $23 million quarterly run rate and expectations to exceed the 2026 savings target; management also expects to surpass $25 million in average quarterly savings during 2027.
• Stepan improved net leverage to 2.4 times and expects continued deleveraging, aided by $28.5 million of land-sale proceeds earmarked for debt repayment; management also raised the quarterly dividend for the 59th consecutive year.
• Free cash flow was only $8 million despite stronger earnings because working capital absorbed $32 million, while Europe and China remained weak in Polymers, crop productivity demand softened, and ongoing raw-material volatility and maintenance costs remain headwinds.

Stepan Stock Up 0.7%

NYSE SCL traded up $0.48 on Wednesday, reaching $65.69. 152,394 shares of the stock traded hands, compared to its average volume of 158,342. The firm’s fifty day simple moving average is $62.67 and its 200 day simple moving average is $56.61. The company has a market cap of $1.49 billion, a price-to-earnings ratio of -547.46 and a beta of 0.94. Stepan has a 12 month low of $41.82 and a 12 month high of $70.00.

Key Stories Impacting Stepan

Here are the key news stories impacting Stepan this week:

• Positive Sentiment: Q3 earnings and revenue beat estimates: Stepan reported adjusted earnings of $0.94 per share, exceeding the $0.73 consensus estimate, while revenue reached $692.2 million versus expectations of $634.3 million. Revenue rose 17.3% year over year, and earnings were up from $0.48 per share in the prior-year quarter. Stepan Q3 earnings report
• Positive Sentiment: Broad-based operating growth: Surfactants sales increased 15% to $486.6 million, Polymers sales rose 24% to $178.7 million, and Specialty Products sales grew 12%. Reported net income increased 64% to $17.8 million, while operating income climbed 19% to $26.0 million. Stepan third-quarter results
• Positive Sentiment: 59th consecutive annual dividend increase: The board raised the quarterly cash dividend to $0.405 per share, extending one of the market’s longest dividend-growth records. The increase strengthens Stepan’s appeal to income-focused investors and signals management confidence in cash generation. Stepan dividend increase
• Positive Sentiment: Debt-reduction opportunity: Stepan sold land near its Millsdale site for $28.5 million, with proceeds designated for debt repayment, potentially improving leverage and financial flexibility.
• Negative Sentiment: Restructuring remains a headwind: The quarter included a $5.6 million pretax charge tied to Project Catalyst, while operating cash flow of $29.3 million remained only modestly above capital expenditures of $21.1 million.

Analysts Set New Price Targets

A number of research analysts have recently commented on SCL shares. Weiss Ratings reissued a “sell (d+)” rating on shares of Stepan in a report on Tuesday. Zacks Research upgraded shares of Stepan from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, September 29th. Seaport Research Partners reissued a “buy” rating and set a $85.00 target price on shares of Stepan in a research note on Friday, August 7th. Finally, Wall Street Zen raised shares of Stepan from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy”.

Stepan Company Profile

Stepan Company (NYSE:SCL) is a global manufacturer of specialty and intermediate chemicals. Founded in 1932 and headquartered in Northfield, Illinois, the company develops products used by manufacturers in consumer and industrial markets.

Stepan’s principal products include surfactants, which are used in detergents, cleaners, personal-care products, agricultural formulations and other applications. The company also produces polyurethane polyols, phthalic anhydride and other specialty chemicals used in insulation, construction materials, coatings, plastics, food packaging and related industrial products.

Stepan serves customers across North America, Latin America, Europe and Asia through a network of manufacturing facilities, research and development operations, and sales organizations.